{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:45:43Z","timestamp":1791049543621,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.canlet.2008.07.011","type":"journal-article","created":{"date-parts":[[2008,9,7]],"date-time":"2008-09-07T18:18:08Z","timestamp":1220811488000},"page":"232-241","source":"Crossref","is-referenced-by-count":19,"title":["Insulin-like growth factor-1 attenuates cisplatin-induced \u03b3H2AX formation and DNA double-strand breaks repair pathway in non-small cell lung cancer"],"prefix":"10.1016","volume":"272","author":[{"given":"Jeong Hee","family":"Jeon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Kyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul Min","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Soo","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2008.07.011_bib1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics, 2007","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2008.07.011_bib2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2008.07.011_bib3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00063198-200307000-00013","article-title":"Evaluation of operability before lung resection","volume":"9","author":"Bolliger","year":"2003","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.canlet.2008.07.011_bib4","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/bmj.311.7010.899","article-title":"Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials","volume":"311","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.canlet.2008.07.011_bib5","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1200\/JCO.1995.13.8.1880","article-title":"Concurrent cisplatin\/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805","volume":"13","author":"Albain","year":"1995","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2008.07.011_bib6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0006-2952(02)01508-3","article-title":"DNA repair mechanisms involved in gemcitabine cytotoxicity and in the interaction between gemcitabine and cisplatin","volume":"65","author":"Crul","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2008.07.011_bib7","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1021\/bi00324a025","article-title":"Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation","volume":"24","author":"Fichtinger-Schepman","year":"1985","journal-title":"Biochemistry"},{"key":"10.1016\/j.canlet.2008.07.011_bib8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1158\/1541-7786.MCR-04-0032","article-title":"Cisplatin sensitizes cancer cells to ionizing radiation via inhibition of nonhomologous end joining","volume":"3","author":"Boeckman","year":"2005","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.canlet.2008.07.011_bib9","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","article-title":"Cisplatin: mode of cytotoxic action and molecular basis of resistance","volume":"22","author":"Siddik","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2008.07.011_bib10","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0962-8924(03)00170-3","article-title":"The cellular response to DNA double-strand breaks: defining the sensors and mediators","volume":"13","author":"Petrini","year":"2003","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.canlet.2008.07.011_bib11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ccr.2006.11.024","article-title":"p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK\/MK2 pathway for survival after DNA damage","volume":"11","author":"Reinhardt","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2008.07.011_bib12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/1357-2725(95)00168-9","article-title":"IGF-I: a mitogen also involved in differentiation processes in mammalian cells","volume":"28","author":"Benito","year":"1996","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.canlet.2008.07.011_bib13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/jnci\/91.2.151","article-title":"Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis","volume":"91","author":"Yu","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2008.07.011_bib14","doi-asserted-by":"crossref","first-page":"F1144","DOI":"10.1152\/ajprenal.00094.2005","article-title":"Activated IGF-1R inhibits hyperglycemia-induced DNA damage and promotes DNA repair by homologous recombination","volume":"289","author":"Yang","year":"2005","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.canlet.2008.07.011_bib15","doi-asserted-by":"crossref","first-page":"7510","DOI":"10.1128\/MCB.23.21.7510-7524.2003","article-title":"Role of the insulin-like growth factor I\/insulin receptor substrate 1 axis in Rad51 trafficking and DNA repair by homologous recombination","volume":"23","author":"Trojanek","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.canlet.2008.07.011_bib16","doi-asserted-by":"crossref","first-page":"42462","DOI":"10.1074\/jbc.C100466200","article-title":"ATM phosphorylates histone H2AX in response to DNA double-strand breaks","volume":"276","author":"Burma","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2008.07.011_bib17","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0960-9822(00)00610-2","article-title":"A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage","volume":"10","author":"Paull","year":"2000","journal-title":"Curr. Biol."},{"key":"10.1016\/j.canlet.2008.07.011_bib18","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/jnci\/dji224","article-title":"New checkpoint blockers begin human trials","volume":"97","author":"Garber","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2008.07.011_bib19","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/jnci\/97.11.790","article-title":"IGF-1: old growth factor shines as new drug target","volume":"97","author":"Garber","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2008.07.011_bib20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.drup.2005.02.003","article-title":"Role of early plasma membrane events in chemotherapy-induced cell death","volume":"8","author":"Dimanche-Boitrel","year":"2005","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.canlet.2008.07.011_bib21","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1210\/en.138.4.1427","article-title":"Specific inhibition of insulin-like growth factor-1 and insulin receptor tyrosine kinase activity and biological function by tyrphostins","volume":"138","author":"P\u00e1rrizas","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.canlet.2008.07.011_bib22","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1200\/JCO.2006.08.2867","article-title":"Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program","volume":"25","author":"Filipits","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2008.07.011_bib23","first-page":"955","article-title":"Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer (Review)","volume":"12","author":"Wang","year":"2004","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2008.07.011_bib24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2174\/0929867033368484","article-title":"Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways","volume":"10","author":"Fuertesa","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.canlet.2008.07.011_bib25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/156800906776842957","article-title":"Gamma-H2AX as a therapeutic target for improving the efficacy of radiation therapy","volume":"6","author":"Kao","year":"2006","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.canlet.2008.07.011_bib26","doi-asserted-by":"crossref","first-page":"7865","DOI":"10.1158\/0008-5472.CAN-07-0353","article-title":"Cisplatin-induced apoptosis involves membrane fluidification via inhibition of NHE1 in human colon cancer cells","volume":"67","author":"Rebillard","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.07.011_bib27","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1128\/MCB.22.7.2375-2387.2002","article-title":"Protein phosphatase 2A forms a molecular complex with Shc and regulates Shc tyrosine phosphorylation and downstream mitogenic signaling","volume":"22","author":"Ugi","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.canlet.2008.07.011_bib28","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1128\/MCB.01868-05","article-title":"Insulin-like growth factor I controls a mutually exclusive association of RACK1 with protein phosphatase 2A and beta1 integrin to promote cell migration","volume":"26","author":"Kiely","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.canlet.2008.07.011_bib29","doi-asserted-by":"crossref","first-page":"6238","DOI":"10.1158\/0008-5472.CAN-07-0288","article-title":"Cholesterol sensitivity of endogenous and myristoylated Akt","volume":"67","author":"Adam","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.07.011_bib30","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/35044005","article-title":"The DNA damage response: putting checkpoints in perspective","volume":"408","author":"Zhou","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2008.07.011_bib31","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/ncb1599","article-title":"Roles of ATM and NBS1 in chromatin structure modulation and DNA double-strand break repair","volume":"9","author":"Berkovich","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2008.07.011_bib32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.biochi.2004.10.019","article-title":"Positive and negative regulation of insulin signaling through IRS-1 phosphorylation","volume":"87","author":"Gual","year":"2005","journal-title":"Biochimie"},{"key":"10.1016\/j.canlet.2008.07.011_bib33","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1161\/01.ATV.0000105902.89459.09","article-title":"Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels","volume":"24","author":"Delafontaine","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.canlet.2008.07.011_bib34","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.onc.1210636","article-title":"Nuclear insulin receptor substrate-1 activates promoters of cell cycle progression genes","volume":"27","author":"Wu","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2008.07.011_bib35","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/ijc.21828","article-title":"IRS-1-Rad51 nuclear interaction sensitizes JCV T-antigen positive medulloblastoma cells to genotoxic treatment","volume":"119","author":"Trojanek","year":"2006","journal-title":"Int. J. Cancer"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383508005545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383508005545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T21:07:01Z","timestamp":1557781621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383508005545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0304383508005545"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2008.07.011","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}